| |
| |
|
| Insider
Information: |
F2 Capital I 2019, Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
1,285,246 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,902,164 |
|
|
| Total
Shares |
1,285,246 |
|
|
| Total
Value |
$1,902,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2019-02-19 |
0 |
2019-12-20 |
1,285,246 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(600,000) |
161,024 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-12-19 |
4 |
S |
$16.47 |
$691,222 |
I/I |
(41,965) |
155,986 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-12-18 |
4 |
S |
$17.01 |
$49,164 |
I/I |
(2,891) |
191,309 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-09-23 |
4 |
S |
$17.31 |
$195,982 |
I/I |
(11,321) |
1,411,656 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-09-20 |
4 |
S |
$17.94 |
$7,263,837 |
I/I |
(405,000) |
1,417,172 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-09-04 |
4 |
S |
$17.55 |
$214,414 |
I/I |
(12,214) |
102,563 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-09-03 |
4 |
S |
$17.01 |
$179,653 |
I/I |
(10,559) |
114,777 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-29 |
4 |
S |
$17.01 |
$62,925 |
I/I |
(3,700) |
125,336 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-28 |
4 |
S |
$17.01 |
$113,941 |
I/I |
(6,700) |
129,036 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-27 |
4 |
S |
$17.01 |
$20,414 |
I/I |
(1,200) |
135,736 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-26 |
4 |
S |
$17.01 |
$495,479 |
I/I |
(29,128) |
136,936 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-23 |
4 |
S |
$17.00 |
$51 |
I/I |
(3) |
166,064 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-22 |
4 |
S |
$17.03 |
$1,703 |
I/I |
(100) |
166,067 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-08-21 |
4 |
S |
$17.00 |
$8,500 |
I/I |
(500) |
166,167 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-02-19 |
4 |
B |
$15.00 |
$10,000,005 |
I/I |
666,667 |
536,962 |
1.5 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,904,594 |
403,629 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
